Riitta Lassila, MD, PhD, University of Helsinki, Helsinki, Finland, discusses the benefit of gene therapies on quality of life (QoL) in patients with hemophilia A and hemophilia B, also commenting on the impact of bleeds on the QoL of children and adults with hemophilia. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.